Patents by Inventor Hans E. Junginger

Hans E. Junginger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition containing two active ingredients for smoking cessation
    Patent number: 6582737
    Abstract: A kit to alleviate tobacco-smoking withdrawal symptoms in a patient is disclosed which comprises: (a) a therapeutically effective amount of nicotine, at least one active nicotine metabolite, a combination of nicotine and an active nicotine metabolite, or an azapirone, or a pharmaceutically acceptable salt thereof; (b) a transdermal delivery system consisting essentially of a bupropion base in a therapeutically effective amount; and (c) a packaging material surrounding (a) and (b).
    Type: Grant
    Filed: September 25, 2001
    Date of Patent: June 24, 2003
    Assignee: Peirce Management, LLC
    Inventors: Mark Hirsh, Kamal K. Midha, Hans E. Junginger
  • PHARMACEUTICAL COMPOSITION CONTAINING TWO ACTIVE INGREDIENTS FOR SMOKING CESSATION
    Publication number: 20030064092
    Abstract: A kit to alleviate tobacco-smoking withdrawal symptoms in a patient is disclosed which comprises:
    Type: Application
    Filed: September 25, 2001
    Publication date: April 3, 2003
    Applicant: PEIRCE MANAGEMENT, LLC
    Inventors: Mark Hirsh, Kamal K. Midha, Hans E. Junginger
  • Patch and method for transdermal delivery of bupropion base
    Patent number: 6312716
    Abstract: The invention includes a patch and method for transdermal delivery of bupropion base. In the method of this invention, a patient is administered a bupropion base in an amount effective to alleviate withdrawal symptoms and to prevent or reduce craving of nicotine in said patient. Alternatively, an effective amount of bupropion base is delivered to alleviate depression in a patient or to treat obesity. A transdermal patch includes a bupropion base. The bupropion base can be mixed with an acceptable pharmaceutical carrier.
    Type: Grant
    Filed: May 2, 2000
    Date of Patent: November 6, 2001
    Assignee: Peierce Management LLC
    Inventors: Kamal K. Midha, Hans E. Junginger, Mark Hirsh
  • Use of (meth) acrylic acid/maleic acid copolymers for improving mucosal permeability
    Patent number: 6004575
    Abstract: (Meth)acrylic acid/maleic acid copolymers for improving mucosal permeability and pharmaceutical compositions containing them are described.
    Type: Grant
    Filed: July 30, 1997
    Date of Patent: December 21, 1999
    Assignee: BASF Aktiengesellschaft
    Inventors: Henrik L. Luessen, Gerrit Borchard, Albertus G. de Boer, Hans E. Junginger, Karl Kolter, Volker Schehlmann, Axel Sanner
  • Dosage units for controlled release of active material
    Patent number: 4666702
    Abstract: A drug delivery system in the form of dosage units for controlled release of active material comprising a core and a coating layer enclosing said core.The coating material contains a microporous synthetic thermoplastic polymer and is compressed into a suitable coating layer enclosing the core with the aid of relatively low compression forces.
    Type: Grant
    Filed: April 11, 1985
    Date of Patent: May 19, 1987
    Assignee: Thiemann Arzneimittel GmbH
    Inventor: Hans E. Junginger